10-Q: Atlantic American Corporation Reports Net Loss in Second Quarter 2024 Amidst Unfavorable Loss Experience

Sentiment:

Quarterly Report


Atlantic American Corporation reported a net loss for the second quarter of 2024, primarily due to unfavorable loss experiences in both its life and health, and property and casualty segments.

Worse than expectedThe company's net loss of $0.7 million in Q2 2024 is worse than the net income of $1.7 million in Q2 2023.The company's operating loss of $1.1 million in Q2 2024 is worse than the operating income of $1.7 million in Q2 2023.The company's premium revenue decreased by 2.3% in Q2 2024 compared to Q2 2023.

Summary

  • Atlantic American Corporation reported a net loss of $0.7 million, or $(0.04) per diluted share, for the three months ended June 30, 2024, compared to a net income of $1.7 million, or $0.08 per diluted share, for the same period in 2023.
  • The company's net loss for the six months ended June 30, 2024, was $2.7 million, or $(0.14) per diluted share, compared to a net income of $0.3 million, or $0.00 per diluted share, for the same period in 2023.
  • The decrease in profitability was primarily due to unfavorable loss experiences in both the life and health, and property and casualty segments, coupled with a decrease in premium revenue in the life and health operations.
  • Premium revenue decreased by 2.3% to $45.0 million for the three months ended June 30, 2024, and by 2.8% to $89.5 million for the six months ended June 30, 2024.
  • Operating income decreased by $2.8 million for the three months ended June 30, 2024, and by $5.7 million for the six months ended June 30, 2024, compared to the same periods in 2023.
  • The company's cash and cash equivalents decreased from $28.3 million at December 31, 2023, to $21.2 million at June 30, 2024.

Sentiment

Score: 3

Explanation: The document indicates a negative sentiment due to the reported net loss, decreased revenue, and unfavorable loss experiences. The identification of a material weakness in internal control further contributes to the negative outlook.

Positives

  • Commissions and underwriting expenses decreased due to a variable commission structure in the property and casualty operations and reduced commission expenses in the life and health operations.
  • Unrealized gains on equity securities partially offset the increase in net loss during the six month period ended June 30, 2024.

Negatives

  • The company experienced unfavorable loss experience in both the life and health, and property and casualty segments.
  • There was a decrease in premium revenue in the life and health operations, particularly in Medicare supplement insurance.
  • The property and casualty segment saw a decline in automobile physical damage premiums due to a downturn in the trucking industry.
  • The company's cash position decreased by $7.1 million in the first half of 2024.

Risks

  • The company faces risks related to changes in claim frequency and severity, which could impact future financial performance.
  • The company's statutory results may differ from GAAP results due to the deferral of acquisition costs and different reserving methods.
  • The company's ability to pay its obligations under the Junior Subordinated Debentures depends on existing cash balances, dividends, tax-sharing payments, and potential future financing arrangements.
  • The company has identified a material weakness in internal control over financial reporting related to the review of insurance reserves and deferred acquisition costs within the life and health segment.

Future Outlook

The company believes that existing cash balances, dividends, fees, and tax-sharing payments from its subsidiaries, and if needed, borrowings under its credit facilities or additional borrowings from financial institutions, will enable the company to meet its liquidity requirements for the foreseeable future.

Management Comments

  • Management believes operating income (loss) is a useful metric for investors because it isolates the core operating results of the Company.
  • Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse effect on the Company's liquidity, capital resources or operations.

Industry Context

The decrease in the automobile physical damage line of business reflects a broader downturn in the trucking industry, while the decrease in Medicare supplement premiums is indicative of challenges in the health insurance market. The company's results are also impacted by general market changes in interest rates and credit spreads.

Comparison to Industry Standards

  • The company's combined ratio of 101.3% for American Southern in Q2 2024 indicates an underwriting loss, which is worse than the industry average for well-performing P&C insurers, which typically aim for a combined ratio below 100%.
  • The loss ratio of 64.0% for Bankers Fidelity in Q2 2024 is higher than the industry average for life and health insurers, indicating higher claims costs relative to premiums.
  • The company's reliance on variable commission structures is a common practice in the insurance industry to align agent incentives with underwriting performance, but the unfavorable loss experience has resulted in lower commissions.
  • The company's investment portfolio is diversified across fixed maturities and equity securities, which is a standard practice for insurance companies to manage risk and generate returns, but the unrealized losses on fixed maturities due to interest rate changes are a common challenge in the current economic environment.

Stakeholder Impact

  • Shareholders are negatively impacted by the net loss and decreased profitability.
  • Employees may be affected by the company's performance and any potential cost-cutting measures.
  • Customers may experience changes in service or product offerings due to the company's financial situation.
  • Suppliers and creditors may face increased scrutiny due to the company's financial challenges.

Next Steps

  • The company is in the process of remediating the material weakness in internal control over financial reporting.
  • The company expects analytical reports to be operational by September 30, 2024, to facilitate the timely detection of anomalous values within the life and health segment.

Key Dates

DateDescription
May 12, 2021The Company entered into a Revolving Credit Agreement with Truist Bank.
March 3, 2021The Company entered into a hosting arrangement with a third party software solutions vendor.
March 22, 2024The Company entered into a First Amendment to its Revolving Credit Agreement, extending the maturity date to March 22, 2027.
June 30, 2024End of the reporting period for the quarterly results.
July 31, 2024Total number of shares of the registrants Common Stock outstanding was 20,399,758.
August 14, 2024Date of the report.
September 30, 2024Expected date for analytical reports to be operational to facilitate the timely detection of anomalous values within the Companys life and health segment.

Keywords

insurance, financial results, net loss, premium revenue, operating income, loss ratio, combined ratio, internal control, financial reporting, Medicare supplement, property and casualty, life and health

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.